To contentTo navigationTo search
Logotype

Welcome to Implantica

Select your region of residence below to learn more about Implantica and RefluxStop™, our innovative solution for GERD.

We are working on making RefluxStop™ available globally.

Europe

RefluxStop™ is CE marked in Europe. It is currently available in:

  • Austria
  • France 
  • Italy
  • Germany
  • Norway
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Europe

USA & Other

RefluxStop® is not available for sale in all other countries including the USA.


For additional information contact our customer support:

[email protected]

USA & Other

You are about to navigate to a different regional section of the website.

Please confirm your country of residence below.

Europe

RefluxStop™ is CE marked in Europe. It is currently available in:

  • Austria
  • France 
  • Italy
  • Germany
  • Norway
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Europe

USA & Other

RefluxStop® is not available for sale in all other countries including the USA.


For additional information contact our customer support:

[email protected]

USA & Other

The share


Implantica AG is a public company listed on Nasdaq First North Premier Growth Market through Swedish Depositary Receipts (SDRs) since 21 September 2020. One SDR represents one underlying Class A share in the Company. The Company has two share classes, Class A and Class B shares.

Ticker:IMP A SDB 
ISIN code:SE0014855029



Largest shareholders

As of  April 10, 2025

NameHolding of capital
Peter Forsell46.6%
Handelsbanken Fonder8.9%
EFG Bank6.9%
UBS3.7%
UBP2.7%
Avanza Pension2.7%
SEB Life2.2%
SIX SIS AG1.6%
Nordea Liv1.4%
Stephan Siegenthaler1.3%
TIN Fonder1.2%
Backahill Utveckling1.1%
LGT Bank1.1%
Fjärde AP-Fonden1.1%
IF1.0%
Largest shareholders83.4%
Other shareholders16.6%